Literature DB >> 2747450

Alzheimer's disease-associated reduction of polysomal mRNA translation.

N S Langstrom1, J P Anderson, H G Lindroos, B Winblad, W C Wallace.   

Abstract

Polysomes from the frontal cortices of individuals who had histopathologically confirmed Alzheimer's disease were compared with polysomes from individuals who exhibited no neuropathological conditions. The cytosolic polysome yield from Alzheimer's disease frontal cortex was reduced 40% compared with that obtained from control frontal cortex. The translational activity per unit polysome of the Alzheimer's disease polysomes was only 50% of control in a reticulocyte lysate in vitro translation assay in which human polysomes do not undergo reinitiation. These differences exhibited brain region specificity in that polysomes isolated from Alzheimer's disease cerebellum were not different from control cerebellar polysomes. Thus, the disruptions are not due to a secondary and general response of the entire brain to the disease. These reductions were reflected by similar decreases in the translation of the mRNA for high molecular weight neurofilament polypeptide. Thus, the inhibition of polysomal mRNA translation is a mechanism by which gene expression is impaired in pathologically involved brain regions of individuals afflicted by Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2747450     DOI: 10.1016/0169-328x(89)90060-0

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  36 in total

1.  Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease.

Authors:  Qunxing Ding; William R Markesbery; Valentina Cecarini; Jeffrey N Keller
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

2.  Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model.

Authors:  Paula Garcia-Esparcia; Georgios Sideris-Lampretsas; Karina Hernandez-Ortega; Oriol Grau-Rivera; Theodoros Sklaviadis; Ellen Gelpi; Isidro Ferrer
Journal:  Am J Neurodegener Dis       Date:  2017-06-15

3.  Aberrant GAP-43 gene expression in Alzheimer's disease.

Authors:  S M de la Monte; S C Ng; D W Hsu
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Oxygen Supplementation Improves Protein Milieu Supportive of Protein Synthesis and Antioxidant Function in the Cortex of Alzheimer's Disease Model Mice-a Quantitative Proteomic Study.

Authors:  Hao Wang; Xiaoyu Hong; Shuiming Li; Yong Wang
Journal:  J Mol Neurosci       Date:  2017-09-21       Impact factor: 3.444

Review 5.  TOR on the brain.

Authors:  Michael G Garelick; Brian K Kennedy
Journal:  Exp Gerontol       Date:  2010-09-16       Impact factor: 4.032

6.  Alzheimer and beta-amyloid-treated fibroblasts demonstrate a decrease in a memory-associated GTP-binding protein, Cp20.

Authors:  C S Kim; Y F Han; R Etcheberrigaray; T J Nelson; J L Olds; T Yoshioka; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 7.  Oxygen free radicals as inducers of heat shock protein synthesis in cultured human neuroblastoma cells: relevance to neurodegenerative disease.

Authors:  R Omar; M Pappolla
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 8.  Translational control in synaptic plasticity and cognitive dysfunction.

Authors:  Shelly A Buffington; Wei Huang; Mauro Costa-Mattioli
Journal:  Annu Rev Neurosci       Date:  2014       Impact factor: 12.449

Review 9.  Translational Control in the Brain in Health and Disease.

Authors:  Wayne S Sossin; Mauro Costa-Mattioli
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

10.  Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice.

Authors:  Brenna C Beckelman; Wenzhong Yang; Nicole P Kasica; Helena R Zimmermann; Xueyan Zhou; C Dirk Keene; Alexey G Ryazanov; Tao Ma
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.